Clinical Trial Update: A Pilot Study of Oxaloacetate in Subjects With Treated PD [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 pilot trial evaluating oxaloacetate in treated Parkinson's disease patients has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Oxaloacetate (oxaloacetate)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Parkinson's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-17